全文获取类型
收费全文 | 1038955篇 |
免费 | 82130篇 |
国内免费 | 6601篇 |
专业分类
耳鼻咽喉 | 13369篇 |
儿科学 | 34880篇 |
妇产科学 | 28946篇 |
基础医学 | 149207篇 |
口腔科学 | 28521篇 |
临床医学 | 95591篇 |
内科学 | 197718篇 |
皮肤病学 | 23365篇 |
神经病学 | 80748篇 |
特种医学 | 40190篇 |
外国民族医学 | 325篇 |
外科学 | 153845篇 |
综合类 | 34878篇 |
一般理论 | 387篇 |
预防医学 | 81307篇 |
眼科学 | 23763篇 |
药学 | 77203篇 |
35篇 | |
中国医学 | 5985篇 |
肿瘤学 | 57423篇 |
出版年
2019年 | 8962篇 |
2018年 | 12155篇 |
2017年 | 9919篇 |
2016年 | 10782篇 |
2015年 | 12931篇 |
2014年 | 17209篇 |
2013年 | 24688篇 |
2012年 | 32426篇 |
2011年 | 34559篇 |
2010年 | 21172篇 |
2009年 | 19527篇 |
2008年 | 31113篇 |
2007年 | 33163篇 |
2006年 | 33498篇 |
2005年 | 31845篇 |
2004年 | 31409篇 |
2003年 | 30839篇 |
2002年 | 29515篇 |
2001年 | 49031篇 |
2000年 | 49294篇 |
1999年 | 40974篇 |
1998年 | 11207篇 |
1997年 | 10103篇 |
1996年 | 9909篇 |
1995年 | 10075篇 |
1994年 | 9361篇 |
1993年 | 8601篇 |
1992年 | 32376篇 |
1991年 | 31599篇 |
1990年 | 31136篇 |
1989年 | 29976篇 |
1988年 | 27233篇 |
1987年 | 27399篇 |
1986年 | 25465篇 |
1985年 | 24641篇 |
1984年 | 18385篇 |
1983年 | 15481篇 |
1982年 | 9256篇 |
1981年 | 8344篇 |
1979年 | 16827篇 |
1978年 | 12191篇 |
1977年 | 10281篇 |
1976年 | 9718篇 |
1975年 | 10153篇 |
1974年 | 12298篇 |
1973年 | 11827篇 |
1972年 | 10878篇 |
1971年 | 10104篇 |
1970年 | 9370篇 |
1969年 | 8713篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
3.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
4.
S. Liu A. E. Patanwala J. M. Naylor N. Levy R. Knaggs J. A. Stevens B. Bugeja D. Begley K. E. Khor E. Lau R. Allen S. Adie J. Penm 《Anaesthesia》2023,78(10):1237-1248
Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty. 相似文献
5.
6.
Jos B. Poell Leon J. Wils Arjen Brink Ralf Dietrich Christine Krieg Eunike Velleuer Ilkay Evren Elisabeth R. Brouns Jan G. de Visscher Elisabeth Bloemena Bauke Ylstra Ruud H. Brakenhoff 《International journal of cancer. Journal international du cancer》2023,152(2):227-238
Oral squamous cell carcinomas (OSCCs) develop in genetically altered epithelium in the mucosal lining, also coined as fields, which are mostly not visible but occasionally present as white oral leukoplakia (OL) lesions. We developed a noninvasive genetic assay using next-generation sequencing (NGS) on brushed cells to detect the presence of genetically altered fields, including those that are not macroscopically visible. The assay demonstrated high accuracy in OL patients when brush samples were compared with biopsies as gold standard. In a cohort of Fanconi anemia patients, detection of mutations in prospectively collected oral brushes predicted oral cancer also when visible abnormalities were absent. We further provide insight in the molecular landscape of OL with frequent changes of TP53, FAT1 and NOTCH1. NGS analysis of noninvasively collected samples offers a highly accurate method to detect genetically altered fields in the oral cavity, and predicts development of OSCC in high-risk individuals. Noninvasive genetic screening can be employed to screen high-risk populations for cancer and precancer, map the extension of OL lesions beyond what is visible, map the oral cavity for precancerous changes even when visible abnormalities are absent, test accuracy of promising imaging modalities, monitor interventions and determine genetic progression as well as the natural history of the disease in the human patient. 相似文献
7.
目的:基于以价值为基础的定价方法,计算核医学学科新增医疗服务项目镭[223 Ra]骨转移瘤治疗的医疗服务价格。为相关新增医疗服务项目的申报和定价打下循证基础,为合理补偿医务人员劳动价值、提升患者服务项目可及性提供依据。方法:采集2021年3—12月使用“镭核素[223 Ra]骨转移瘤治疗资源投入及费用数据采集表”相关数据,开展专家访谈进行系数赋值和基线对照项目确定,得到镭[223 Ra]骨转移瘤治疗服务各个环节的成本和新增服务的价值。结果:镭[223 Ra]骨转移瘤治疗服务按服务特点分为注射前评估、治疗计划、给药、给药后监测、废弃物处理与监测等环节,各环节3地平均人力耗时分别为104分钟、39分钟、25分钟、72分钟和56分钟,中位物耗成本为48.20元,3地总成本(平均人力成本+中位物耗成本)为763.68元。结合系数赋值结果和基线对比项目,得到新增项目的价值为810.19元。结论:运用基于技术难度和风险程度的价值定价理论,计算镭[223 Ra]骨转移瘤治疗新增医疗服务项目的服务价值,建议以价值作为服务定价依据。该定价公式和研究方法不仅可用于其他核医学学科新增服务项目的定价,还适用于现行医疗服务项目的价格动态调整,为未来学科价格工作提供方法学参考。 相似文献
8.
Qing-Yang Que Lin-Cheng Zhang Jia-Qi Bao Sun-Bin Ling Xiao Xu 《World journal of gastrointestinal surgery》2022,14(5):397-408
Over the last 40 years, the incidence and prevalence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) have continued to increase. Compared to other epithelial neoplasms in the same organ, GEP-NENs exhibit indolent biological behavior, resulting in more chances to undergo surgery. However, the role of surgery in high-grade or advanced GEP-NENs is still controversial. Surgery is associated with survival improvement of well-differentiated high-grade GEP-NENs, whereas poorly differentiated GEP-NENs that may benefit from resection require careful selection based on Ki67 and other tissue bio markers. Additionally, surgery also plays an important role in locally advanced and metastatic disease. For locally advanced GEP-NENs, isolated major vascular involvement is no longer an absolute contraindication. In the setting of metastatic GEP-NENs, radical intended surgery is recommended for patients with low-grade and resectable metastases. For unresectable metastatic disease, a variety of surgical approaches, including cytoreduction of liver metastasis, liver transplantation, and surgery after neoadjuvant treatment, show survival benefits. Primary tumor resection in GEP-NENs with unresectable metastatic disease is associated with symptom control, prolonged survival, and improved sensitivity toward systemic therapies. Although there is no established neoadjuvant or adjuvant strategy, increasing attention has been given to this emerging research area. Some studies have reported that neoadjuvant therapy effectively reduces tumor burden, improves the effectiveness of subsequent surgery, and decreases surgical complications. 相似文献
9.
目的 基于世界卫生组织康复胜任力架构(RCF),构建以胜任力为本位并且满足残疾学生教育康复需求特点的本科层次特殊教育专业,提升特殊教育专业建设的水平,适应基于胜任力教育发展的要求。方法 运用RCF的理论与方法,参照《特殊教育教师专业标准(试行)》《特殊教育专业认证标准》和《特殊教育专业师范生教师职业能力标准》,分析学校教育情境中特殊教育教师的胜任力要求。结果 构建了基于RCF的特殊教育教师胜任力架构,提出了基于RCF的特殊教育专业设置原则和基于RCF的特殊教育专业建设的原则,根据学校教育环境的特点,建立了适用于本科层次特殊教育专业的胜任力模式。结论 RCF作为一个服务全民健康的全球康复胜任力架构,其理论与方法对于构建特殊教育专业基于胜任力的教育体系具有重要的意义。基于RCF构建了本科层次特殊教育专业的原则、方法、教育目标以及方法体系,促进实施国家《特殊教育教师专业标准(试行)》、《特殊教育专业认证标准》和《特殊教育专业师范生教师职业能力标准》。 相似文献
10.
目的分析维生素D3辅助治疗哮喘合并呼吸道感染对气道重塑及免疫功能的影响。 方法选取我院2020年1月至2021年1月收治的56例哮喘患者为对象,随机分为两组,其中采取常规治疗为对照组24例,采用维生素D3辅助治疗为观察组32例。比较两组临床疗效,咳嗽、咳痰、气喘、胸闷以及肺内哮鸣声消失时间,T细胞亚群变化以及气道重塑指标变化,比较不良反应发生情况。 结果观察组临床治疗总有效率显著高于对照组,同时咳嗽、咳痰、气喘、胸闷以及肺哮鸣音等消失时间明显好于对照组(P<0.05);观察组CD4+、CD4+/CD8+显著高于对照组(P<0.05);观察组高于对照组(P<0.05)。两组不良反应率差异(P>0.05)。 结论使用维生素D3辅助治疗哮喘合并呼吸道感染可增强患者的免疫功能,延缓气道重塑纤维化进程,安全性高。 相似文献